It’s confirmed by Dr. Alex F. Herrera from Brigham & Women’s Hospital in Boston that Diarrhea is an expected complication of Hematopoietic Stem Cell Transplantation (HSCT). This syndrome is called colitis. It is defined as a constant diarrheal illness and it’s not cause d by acute graft-vs-host disease (GVHD).
A new study made by the hospital reveals there are cases of cord colitis syndrome and it occurred in eleven of one hundred four patients. These cases have been characterized in terms of clinical and pathological features. Its onset after transplantation is 131 days. Dr. Herrera is the author of September Issue of New England Journal of Medicine and he wrote,
“The cord colitis syndrome is clinically and histopathologically distinct from acute GVHD and other causes of diarrhea in patients who have undergone cord-blood HSCT and is relatively common in this patient population. The syndrome should be considered in such patients who have diarrhea that is not attributable to other causes.”
“The cord colitis syndrome responds to antibacterial therapy, which suggests an infectious, possibly bacterial, cause. The histopathological findings observed in the cord colitis syndrome are similar to those seen in Crohn’s disease. There is evidence that antibiotics may be a useful adjunctive therapy in patients with Crohn’s disease. A greater understanding of the cord colitis syndrome may provide insights into the pathophysiology of Crohn’s disease.”
Viacord is a private processing and storage company established in 1993 to give expectant parents an opportunity to bank their children’s cord blood with comfort and security.
Viacord is accredited by the American Association of Blood Banks (AABB) and registered in states with current regulations. Viacord has distinguished itself in the medical community through a relentless dedication to high quality standards.
Prior to launching their Cord Blood Banking Service, Viacord worked closely with the following institutions conducting extensive research and validation studies to set the highest standards regarding the collection, processing, and storage of cord blood:
Obstetrics Program at Brigham and Women’s Hospital in Boston, MA
The Children’s Hospital in Boston, MA
The Christ Hospital in Cincinnati, OH
The University of Cincinnati’s Hoxworth Blood Center
245 First Street
Cambridge, MA 02142
Outside U.S. 617-914-3900
Women delivering their babies at any of Boston’s famous “hub” hospitals – Mass General, Dana Farber Cancer Institute, Brigham & Women’s Hospital, Beth Israel Deaconess Hospital, ChildrenÕs Hospital, Tufts Medical School, Boston University Medical School, and Harvard Medical School – can expect to privately store their baby’s cord blood with either of the following commercial companies. Women wishing to donate the cord blood should discuss it with their OB to determine the best venue.
New England Cord Blood Bank, Inc. (NECBB) is a private cord blood processor and storage company in Boston. They say that at their state-of-the-art facility they process, test, verify, cryopreserve, and store blood collected from the umbilical cord in their in-house Laboratory. The laboratory is licensed by the Massachusetts Department of Health and has a CLIA Federal Laboratory license. NECBB is in the process of receiving American Association of Blood Banks (AABB) accreditation.
New England Cord Blood Bank, Inc.
153 Needham Street
Newton, MA 02464
fax (617) 244-4483